Emyria Ltd: So crazy it might just work – psychedelic drugs to treat mental health
Listen to ASX-listed Emyria Ltd Managing Director Dr Michael Winlo talk to Matt Birney on the Bulls N’ Bears Report about Emyria’s research and development of “party drug” MDMA to tackle the $219b a year mental health market.

Hastings Technology Metals: A rare earths game changer – a mothballed plant that has never fired a shot
02:58

Australian Oil Company: Remarkable - an ASX small cap actually producing oil!
02:31

Critical Resources: Could this patented lithium battery tech change the playing field?
03:12